Skip to content
★ Sign in to follow
WS

William S. Craig

Cadence Pharmaceuticals Inc
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€268k

Latest filing published 18 Dec 2009 for CADENCE PHARMACEUTICALS INC, €1,394.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

William S. Craig: trading record in brief

William S. Craig discloses dealings in Cadence Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 20 February 2008 to 17 December 2009, the count stands at 16 filings.

Every open-market trade on record is a sale: 7 sales worth €268k. Besides market trades, the filings include 1 share grant and 8 option exercises. Since January 2009: no purchases and 7 sales on the market.

The record was last updated on 18 December 2009 with an option exercise (€1,394) in Cadence Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to William S. Craig

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations